Biophan Technologies Expands Intellectual Property Position, Secures Major Partnership with Boston Scientific Corp.

Strategic Insights -

Biophan Technologies, Inc., a leader in biomedical device safety, has strengthened its intellectual property position and secured a significant partnership with Boston Scientific Corp. The company's innovative solution makes biomedical devices MRI-safe, a critical breakthrough for the medical industry. Michael Weiner, President and CEO of Biophan, highlighted the company's progress, including its relationship with Boston Scientific, which has been instrumental in validating Biophan's technology and providing valuable insights. The company's Squiggle Motor and its applications were also discussed, as well as Biophan's current cash position and upcoming milestones.

Key Takeaways:

  • Biophan Technologies has developed a solution to make pacemakers, neurostimulators, and other implantable devices safe in MRI environments.
  • The company has secured a significant partnership with Boston Scientific Corp., with the relationship moving into its next phase, providing crucial validation and support.
  • Biophan's Squiggle Motor has numerous applications, including biomedical device safety.
  • The company currently maintains a positive cash position and is approaching upcoming milestones.
  • Biophan Technologies receives support from Boston Scientific, emphasizing the significant partnership's impact on the company's growth.
  • Michael Weiner, Biophan's President and CEO, emphasized the importance of the Boston Scientific partnership in the interview.

Statistics:

  • Biophan Technologies has a solution to make MRI-safe over 100 different kinds of biomedical devices.
  • The company's partnership with Boston Scientific Corp. has been in place since November 2003.
  • Biophan has received payment from Boston Scientific Corp. for their relationship.
  • Michael Weiner has led Biophan Technologies since the company's inception.
  • The company has a Squiggle Motor with various applications.
  • Biophan's relationship with Boston Scientific Corp. has been an instrumental part of the company's growth.

Sources:

  • Digital Wall Street, Inc. Copyright 2004 Market Wire, All rights reserved.
  • COMTEX (http://www.comtexnews.com)